CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
UNIVERSITE PARIS-SACLAY (France)
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (Spain)
UNIVERSITY OF SEVILLE (Spain)
Inventor
Guardiola Salmerón, Consuelo
Márquez, Augusto
Muñoz-Berbel, Xavier
Del Carmen Jiménez-Ramos, Maria
García López, Javier
Abstract
The invention relates to a device for measuring the dose delivered through a radiosensitive film under exposure to ionizing radiations, to a system comprising such device and to the use of such device. More particularly, the device comprises a reflection film; at least one light source; a radiosensitive film; and an optical sensor system comprising a 2-D array of one or more photoresistor units and/or semiconductor units. The present invention also relates to a system comprising the device previously described; a readout integrated circuit unit connected to the optical sensor system of the device; and a processing unit connected to the readout integrated circuit. The present invention also relates to the use of a device as previously described.
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
UNIVERSITE PARIS-SACLAY (France)
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (Spain)
UNIVERSITY OF SEVILLE (Spain)
Inventor
Guardiola Salmerón, Consuelo
Márquez, Augusto
Muñoz-Berbel, Xavier
Del Carmen Jiménez-Ramos, María
García López, Javier
Abstract
The invention relates to a device for measuring the dose delivered through a radiosensitive film under exposure to ionizing radiations, to a system comprising such device and to the use of such device. More particularly, the device comprises a reflection film; at least one light source; a radiosensitive film; and an optical sensor system comprising a 2-D array of one or more photoresistor units and/or semiconductor units. The present invention also relates to a system comprising the device previously described; a readout integrated circuit unit connected to the optical sensor system of the device; and a processing unit connected to the readout integrated circuit. The present invention also relates to the use of a device as previously described.
In this document, PEGA nanoparticles are provided that encapsulate terpenoids and cannabinoids and pharmaceutical compositions which comprise the nanoparticles. Additionally, methods are provided for obtaining and using PEGA nanoparticles which encapsulate terpenoids and cannabinoids for therapeutic applications.
A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61P 9/00 - Drugs for disorders of the cardiovascular system
In this document, PEGA nanoparticles are provided that encapsulate terpenoids and cannabinoids and pharmaceutical compositions which comprise the nanoparticles. Additionally, methods are provided for obtaining and using PEGA nanoparticles which encapsulate terpenoids and cannabinoids for therapeutic applications.
A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61P 9/00 - Drugs for disorders of the cardiovascular system
patents
